Skip to main content
Anteris Technologies Global Corp. logo

Anteris Technologies Global Corp. — Investor Relations & Filings

Ticker · AVR ISIN · US03675P1021 ASX Manufacturing
Filings indexed 1,664 across all filing types
Latest filing 2024-11-01 Regulatory Filings
Country US United States of America
Listing ASX AVR

About Anteris Technologies Global Corp.

https://anteristech.com/

Anteris Technologies is a structural heart company focused on the development and commercialization of medical devices for heart valve disease. Its lead product is the DurAVR® Transcatheter Heart Valve (THV), a biomimetic valve designed for patients with severe aortic stenosis. The DurAVR® THV is engineered to mimic the performance of a healthy human aortic valve, aiming to restore normal, laminar blood flow. Clinical studies have shown the device delivers a favorable hemodynamic profile, characterized by low pressure gradients and a significant reduction in prosthesis-patient mismatch (PPM), even in patients with challenging anatomies. The company is advancing its technology through pivotal clinical trials to establish a new standard in transcatheter aortic valve replacement (TAVR) and improve long-term patient outcomes.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2024
Regulatory Filings
2024-11-01 English
Change in substantial holding 4 pages 254.8KB
Major Shareholding Notification Classification · 100% confidence The document is titled 'Form 604' and references the Corporations Act 2001 Section 671B, which pertains to notices of change of interests of substantial holders. It details changes in voting power, relevant interests, and associations of a substantial shareholder (L1 Capital Pty Ltd) in Anteris Technologies Ltd. The content includes specific shareholding changes, dates, and voting power percentages. This type of filing is a notification of changes in major shareholdings, not a financial report, management announcement, or other categories. Therefore, it fits the definition of 'Major Shareholding Notification' (MRQ). The document length and detail confirm it is the actual notice, not just an announcement of a report or a certification.
2024-10-31 English
Anteris Secures Bridging Facility 4 pages 282.4KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 31 October 2024 regarding Anteris Technologies Ltd entering into a secured convertible note facility with Obsidian Global Partners to provide additional funding support through to the completion of a US IPO. The content details the terms of the facility, drawdowns, convertible notes, options, repayment terms, and interaction with the proposed re-domiciliation and IPO. It is a detailed update on the company's financing activities and capital structure changes, including convertible notes and options issuance. There is no indication that this is a full financial report, audit report, or earnings release. It is not a regulatory filing or announcement of voting results, nor is it a management or investor presentation. The document is clearly an update on capital raising and financing arrangements. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and detail support this classification with high confidence.
2024-10-30 English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 487.5KB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Quarterly Activity Report for the Period to 30 September 2024' and contains detailed operational and financial information for the quarter ended 30 September 2024. It includes unaudited financial results, cash flow statements, operational highlights, clinical study preparations, manufacturing updates, and financial performance including cash inflows and outflows. The document also discusses post-quarter events and updates on a significant transaction (redomiciliation and IPO). The length is substantial (15,000 characters), and it contains substantive financial data and analysis for a period shorter than a full fiscal year. This matches the definition of an Interim / Quarterly Report (IR). It is not merely an announcement or a certification, but a comprehensive report with financial and operational details for the quarter. Q3 2024
2024-10-30 English
Notification of cessation of securities - AVR 5 pages 17.1KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the cessation of certain securities (warrants) for Anteris Technologies Ltd. It includes specific information about the securities that have ceased, the reason for cessation, dates, and the impact on issued capital. The document is a formal announcement to the ASX about changes in the company's issued capital, specifically the cessation of certain securities. It does not contain financial statements, management discussion, or detailed financial results. It is not a report but an official notification of a capital change event. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length (6028 characters) and content confirm it is a full announcement rather than a brief notice or a report publication announcement.
2024-10-28 English
Regulatory Filings 2024
Regulatory Filings
2024-10-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.